Analgesics Market - Forecast(2024 - 2030)

Report Code: HCR 0116 Report Format: PDF + Excel

Analgesics Market Overview:

As documented by the National Institute of Health in 2016, 20% of adults in the U.S. suffer from chronic pain and eight percent had high-impact chronic pain.[1] A report covering proceedings of the last decade from National Center for Health Statistics states that one in every four Americans has suffered from pain that lasts longer than a day.[2] With increasing instances of arthritis and acute chronic diseases, pain management has become a major area of concern with healthcare professionals across the globe. Owing to these developments, demand for analgesics and painkillers (a drug used to achieve analgesia, or relief from pain) is gaining momentum. The global analgesic market size is estimated to be $26.462.5 billion as of 2018. With catapulting incidences of inflammation, physiological injury, cancer treatments, neuropathic conditions, surgeries, wounds, and phantom aches amalgamated with escalating geriatric population, global market demand for analgesics is estimated to progress at a CAGR of 2.34% during the forecast period 2019-2025.

Analgesics Market Outlook:

By type, the analgesic therapeutics market is broadly segmented into opioids (those containing opium) and non-opioids (those without opium).In terms of how the treatment is injected, the market is classified into oral injection, intravenous injection, rectal injection, transdermal injection, and topical injection. Further inspection of revenue generated from the different segments indicates oral injection to be the fastest growing segment progressing at a CAGR of 2.41% going through 2025. The oral type is gaining commercial momentum with higher sales owing to approval of countless over-the-counter (OTC) analgesics drugs which do not require any prescriptions. Oral analgesics are easily accessible at pharmaceuticals, in various form such as capsules and tablets, across the globe.

APAC, with 38.8% share of the global analgesics market demand in 2018, is slated to become the most lucrative zone for the analgesics medication industry. The sheer affluence of this region can be attributable to various factors such as –

  • Crocin, manufactured by GlaxoSmithKline Asia Private Limited (GSKAP), is the leading analgesics brand in India with the product available in liquid as well as solid form. It falls under the non-prescription (OTC) category with more than two million tablets sold each day in India, and with about 20 tablets per second. This alone is a mega influencer in the APAC’s analgesics market, aided considerably by prevalence of a self-medication trend among individuals.
  • Taking note of the densely populated economy of China, ChinaPower states that the Chinese population is growing older at a faster rate as compared to other parts of the world.[3]  China’s one-child policy, coupled with rapid developments in health care, has led to an increase in life expectancy and a decrease in the birth rate, consequently increasing the old age population that is dependent on the analgesic drug market.

Analgesics Market Trends and Growth Drivers:

  • Epidemic growth in incidences of acute chronic ailments such as heart disease, cancer, diabetes, stroke, and arthritis is a major factor  behind increasing demand for the analgesics drugs market. According to its Department of Health, about 40% of adults in New York State suffer from a chronic disease and 23% of the state’s hospitalization is due to chronic diseases.[4] Chronic disease markets such as these are steadily fuelling growth of the analgesics market.
  • Development of pain management guidelines with suggestions to employ opioids in the form of drugs, by elite organizations, is propelling the analgesics market through clinical acceptance. For instance, the World Health Organization (WHO) recommends a three-level ladder approach to pain management, which includes the use of drugs with opioid contents.  
  • Favorable compensation situation in North America and Western Europe for pain management, for patients with cancer pain, is estimated to determine positive growth for the analgesics market. For example, the Pain Management Best Practices Inter-Agency Task Force was set up by the U.S. Department of Health & Human Services (HHS) in August 2017 to detect breaches or irregularities in best practices for pain management, recommend updates and recommendations to address identified gaps or inconsistencies and, as appropriate, submit updates to concerned federal agencies and the public. With federal bodies taking charge of pain management, influx of investment is expected into the analgesic market.
  • Every day, an estimated 90 Americans die of an opioid overdose from prescription opioids, which is a major factor upsetting the market.[6] In September 2016, Endo Pharmaceuticals voluntarily ceased endorsing opioid products to healthcare professionals and eradicated its entire line of pain products. Endo also voluntarily withdrew one of their drugs from the U.S. market, in compliance with FDA regulations moderating the risks of opioid abuse. Several manufacturers are now directing production towards commercializing opioids with abuse deterrence properties, to reduce the abusive consumption of opioids for non-medical purposes, which is a disruptive trend projected towards recovering the losses sustained by the analgesics market due to abuse of opioids.


Analgesics Market

Analgesics Market Players Perspective:

Some key players operating in the analgesics market are Bayer AG, Novartis AG, GlaxoSmithKline PLC, Pfizer Inc., Johnson & Johnson, Reckitt Benckiser (RB), Endo Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly and Company, and Sanofi.

Analgesics Market Research Scope:

The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the analgesics market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the various types of innovations in analgesics market, and their specific advantages to the market.

The Analgesics Market report also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:

  • North America: The U.S., Canada, Mexico
  • South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica
  • Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark
  • APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong
  • Middle East and Africa: Israel, South Africa, Saudi Arabia

 For more Lifesciences and Healthcare related reports, please click here

1. Analgesics Market - Overview
1.1. Definitions and Scope
2. Analgesics Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. Analgesics Market 
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis 
4. Analgesics Market – Startup companies Scenario Premium
4.1. Top 10 startup company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Market Shares
4.1.4. Market Size and Application Analysis
4.1.5. Venture Capital and Funding Scenario
5. Analgesics Market – Industry Market Entry Scenario Premium
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing business index
5.3. Case studies of successful ventures
5.4. Customer Analysis – Top 10 companies
6. Analgesics Market Forces
6.1. Drivers
6.2. Constraints
6.3. Challenges
6.4. Porters five force model
6.4.1. Bargaining power of suppliers
6.4.2. Bargaining powers of customers
6.4.3. Threat of new entrants
6.4.4. Rivalry among existing players
6.4.5. Threat of substitutes 
7. Analgesics Market -Strategic analysis
7.1. Value chain analysis
7.2. Opportunities analysis
7.3. Product life cycle
7.4. Suppliers and distributors Market Share
8. Analgesics Market – By Type (Market Size -$Million / $Billion)
8.1. Market Size and Market Share Analysis 
8.2. Application Revenue and Trend Research
8.3. Product Segment Analysis
8.3.1. Simple analgesics
8.3.2. Non steroidal anti inflammatory drugs (NSAIDS)
8.3.3. Opioids 
9. Analgesics Market – By Treatment Injection Route (Market Size -$Million / $Billion)
9.1. Oral Injection
9.2. Intravenous Injection
9.3. Rectal Injection
9.4. Transdermal Injection
9.5. Topical Injection
10. Analgesics - By Geography (Market Size -$Million / $Billion)
10.1. Analgesics Market - North America Segment Research
10.2. North America Market Research (Million / $Billion)
10.2.1. Segment type Size and Market Size Analysis 
10.2.2. Revenue and Trends
10.2.3. Application Revenue and Trends by type of Application
10.2.4. Company Revenue and Product Analysis
10.2.5. North America Product type and Application Market Size
10.2.5.1. U.S.
10.2.5.2. Canada 
10.2.5.3. Mexico 
10.2.5.4. Rest of North America
10.3. Analgesics - South America Segment Research
10.4. South America Market Research (Market Size -$Million / $Billion)
10.4.1. Segment type Size and Market Size Analysis 
10.4.2. Revenue and Trends
10.4.3. Application Revenue and Trends by type of Application
10.4.4. Company Revenue and Product Analysis
10.4.5. South America Product type and Application Market Size
10.4.5.1. Brazil  
10.4.5.2. Venezuela
10.4.5.3. Argentina
10.4.5.4. Ecuador
10.4.5.5. Peru
10.4.5.6. Colombia 
10.4.5.7. Costa Rica
10.4.5.8. Rest of South America
10.5. Analgesics - Europe Segment Research
10.6. Europe Market Research (Market Size -$Million / $Billion)
10.6.1. Segment type Size and Market Size Analysis 
10.6.2. Revenue and Trends
10.6.3. Application Revenue and Trends by type of Application
10.6.4. Company Revenue and Product Analysis
10.6.5. Europe Segment Product type and Application Market Size
10.6.5.1. U.K  
10.6.5.2. Germany 
10.6.5.3. Italy 
10.6.5.4. France
10.6.5.5. Netherlands
10.6.5.6. Belgium
10.6.5.7. Spain
10.6.5.8. Denmark
10.6.5.9. Rest of Europe
10.7. Analgesics – APAC Segment Research
10.8. APAC Market Research (Market Size -$Million / $Billion)
10.8.1. Segment type Size and Market Size Analysis 
10.8.2. Revenue and Trends
10.8.3. Application Revenue and Trends by type of Application
10.8.4. Company Revenue and Product Analysis
10.8.5. APAC Segment – Product type and Application Market Size
10.8.5.1. China 
10.8.5.2. Australia
10.8.5.3. Japan 
10.8.5.4. South Korea
10.8.5.5. India
10.8.5.6. Taiwan
10.8.5.7. Malaysia
11. Analgesics Market - Entropy
11.1. New product launches
11.2. M&A's, collaborations, JVs and partnerships
12. Analgesics Market – Industry / Segment Competition landscape Premium
12.1. Market Share Analysis
12.1.1. Market Share by Country- Top companies
12.1.2. Market Share by Region- Top 10 companies
12.1.3. Market Share by type of Application – Top 10 companies
12.1.4. Market Share by type of Product / Product category- Top 10 companies
12.1.5. Market Share at global level- Top 10 companies
12.1.6. Best Practises for companies
13. Analgesics Market – Key Company List by Country Premium
14. Analgesics Market Company Analysis
14.1. Market Share, Company Revenue, Products, M&A, Developments
14.2. GlaxoSmithKline
14.3. Pfizer Inc
14.4. Novatis AG
14.5. Bayer Healthcare
14.6. Reckitt Benckiser (RB)
14.7. Bristol-Myers Squibb
14.8. Endo Pharmaceuticals
14.9. Sanofi
14.10. Purdue Pharma
14.11. Johnson & Johnson
14.12. Company 12
14.13. Company 13
14.14. Company 14 and more
"*Financials would be provided on a best efforts basis for private companies"
15. Analgesics Market -Appendix
15.1. Abbreviations
15.2. Sources
16. Analgesics Market -Methodology Premium
16.1. Research Methodology
16.1.1. Company Expert Interviews
16.1.2. Industry Databases
16.1.3. Associations
16.1.4. Company News
16.1.5. Company Annual Reports
16.1.6. Application Trends
16.1.7. New Products and Product database
16.1.8. Company Transcripts
16.1.9. R&D Trends
16.1.10. Key Opinion Leaders Interviews
16.1.11. Supply and Demand Trends
List of Tables:

Table 1: Analgesics Market Overview 2021-2026
Table 2: Analgesics Market Leader Analysis 2018-2019 (US$)
Table 3: Analgesics Market Product Analysis 2018-2019 (US$)
Table 4: Analgesics Market End User Analysis 2018-2019 (US$)
Table 5: Analgesics Market Patent Analysis 2013-2018* (US$)
Table 6: Analgesics Market Financial Analysis 2018-2019 (US$)
Table 7: Analgesics Market Driver Analysis 2018-2019 (US$)
Table 8: Analgesics Market Challenges Analysis 2018-2019 (US$)
Table 9: Analgesics Market Constraint Analysis 2018-2019 (US$)
Table 10: Analgesics Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Analgesics Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Analgesics Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Analgesics Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Analgesics Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Analgesics Market Value Chain Analysis 2018-2019 (US$)
Table 16: Analgesics Market Pricing Analysis 2021-2026 (US$)
Table 17: Analgesics Market Opportunities Analysis 2021-2026 (US$)
Table 18: Analgesics Market Product Life Cycle Analysis 2021-2026 (US$)
Table 19: Analgesics Market Supplier Analysis 2018-2019 (US$)
Table 20: Analgesics Market Distributor Analysis 2018-2019 (US$)
Table 21: Analgesics Market Trend Analysis 2018-2019 (US$)
Table 22: Analgesics Market Size 2018 (US$)
Table 23: Analgesics Market Forecast Analysis 2021-2026 (US$)
Table 24: Analgesics Market Sales Forecast Analysis 2021-2026 (Units)
Table 25: Analgesics Market, Revenue & Volume,By Type, 2021-2026 ($)
Table 26: Analgesics Market By Type, Revenue & Volume,By Simple analgesics, 2021-2026 ($)
Table 27: Analgesics Market By Type, Revenue & Volume,By Non steroidal anti inflammatory drugs (NSAIDS), 2021-2026 ($)
Table 28: Analgesics Market By Type, Revenue & Volume,By Opioids, 2021-2026 ($)
Table 29: Analgesics Market, Revenue & Volume,By Treatment Injection Route , 2021-2026 ($)
Table 30: Analgesics MarketBy Treatment Injection Route , Revenue & Volume,By Oral Injection, 2021-2026 ($)
Table 31: Analgesics MarketBy Treatment Injection Route , Revenue & Volume,By Intravenous Injection, 2021-2026 ($)
Table 32: Analgesics MarketBy Treatment Injection Route , Revenue & Volume,By Rectal Injection, 2021-2026 ($)
Table 33: Analgesics MarketBy Treatment Injection Route , Revenue & Volume,By Transdermal Injection, 2021-2026 ($)
Table 34: Analgesics MarketBy Treatment Injection Route , Revenue & Volume,By Topical Injection, 2021-2026 ($)
Table 35: North America Analgesics Market, Revenue & Volume,By Type, 2021-2026 ($)
Table 36: North America Analgesics Market, Revenue & Volume,By Treatment Injection Route , 2021-2026 ($)
Table 37: South america Analgesics Market, Revenue & Volume,By Type, 2021-2026 ($)
Table 38: South america Analgesics Market, Revenue & Volume,By Treatment Injection Route , 2021-2026 ($)
Table 39: Europe Analgesics Market, Revenue & Volume,By Type, 2021-2026 ($)
Table 40: Europe Analgesics Market, Revenue & Volume,By Treatment Injection Route , 2021-2026 ($)
Table 41: APAC  Analgesics Market, Revenue & Volume,By Type, 2021-2026 ($)
Table 42: APAC  Analgesics Market, Revenue & Volume,By Treatment Injection Route , 2021-2026 ($)
Table 43: Middle East & Africa Analgesics Market, Revenue & Volume,By Type, 2021-2026 ($)
Table 44: Middle East & Africa Analgesics Market, Revenue & Volume,By Treatment Injection Route , 2021-2026 ($)
Table 45: Russia Analgesics Market, Revenue & Volume,By Type, 2021-2026 ($)
Table 46: Russia Analgesics Market, Revenue & Volume,By Treatment Injection Route , 2021-2026 ($)
Table 47: Israel Analgesics Market, Revenue & Volume,By Type, 2021-2026 ($)
Table 48: Israel Analgesics Market, Revenue & Volume,By Treatment Injection Route , 2021-2026 ($)
Table 49: Top Companies 2018 (US$) Analgesics Market, Revenue & Volume,,
Table 50: Product Launch 2018-2019 Analgesics Market, Revenue & Volume,,
Table 51: Mergers & Acquistions 2018-2019 Analgesics Market, Revenue & Volume,,


List of Figures:

Figure 1: Overview of Analgesics Market 2021-2026
Figure 2: Market Share Analysis for Analgesics Market 2018 (US$)
Figure 3: Product Comparison in Analgesics Market 2018-2019 (US$)
Figure 4: End User Profile for Analgesics Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Analgesics Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Analgesics Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Analgesics Market 2018-2019
Figure 8: Ecosystem Analysis in Analgesics Market 2018
Figure 9: Average Selling Price in Analgesics Market 2021-2026
Figure 10: Top Opportunites in Analgesics Market 2018-2019
Figure 11: Market Life Cycle Analysis in Analgesics Market
Figure 12: Global By Type Analgesics Market Revenue, 2021-2026 ($)
Figure 13: Global By Treatment Injection Route Analgesics Market Revenue, 2021-2026 ($)
Figure 14: Global Analgesics Market - By Geography
Figure 15: Global Analgesics Market Value & Volume, By Geography, 2021-2026 ($) 
Figure 16: Global Analgesics Market CAGR, By Geography, 2021-2026 (%)
Figure 17: North America Analgesics Market Value & Volume, 2021-2026 ($)
Figure 18: US Analgesics Market Value & Volume, 2021-2026 ($)
Figure 19: US GDP and Population, 2018-2019 ($)
Figure 20: US GDP – Composition of 2018, By Sector of Origin
Figure 21: US Export and Import Value & Volume, 2018-2019 ($)
Figure 22: Canada Analgesics Market Value & Volume, 2021-2026 ($)
Figure 23: Canada GDP and Population, 2018-2019 ($)
Figure 24: Canada GDP – Composition of 2018, By Sector of Origin
Figure 25: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 26: Mexico Analgesics Market Value & Volume, 2021-2026 ($)
Figure 27: Mexico GDP and Population, 2018-2019 ($)
Figure 28: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 29: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 30: South America Analgesics MarketSouth America 3D Printing  Market Value & Volume, 2021-2026 ($)
Figure 31: Brazil Analgesics Market Value & Volume, 2021-2026 ($)
Figure 32: Brazil GDP and Population, 2018-2019 ($)
Figure 33: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 34: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 35: Venezuela Analgesics Market Value & Volume, 2021-2026 ($)
Figure 36: Venezuela GDP and Population, 2018-2019 ($)
Figure 37: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 38: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 39: Argentina Analgesics Market Value & Volume, 2021-2026 ($)
Figure 40: Argentina GDP and Population, 2018-2019 ($)
Figure 41: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 42: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 43: Ecuador Analgesics Market Value & Volume, 2021-2026 ($)
Figure 44: Ecuador GDP and Population, 2018-2019 ($)
Figure 45: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 46: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 47: Peru Analgesics Market Value & Volume, 2021-2026 ($)
Figure 48: Peru GDP and Population, 2018-2019 ($)
Figure 49: Peru GDP – Composition of 2018, By Sector of Origin
Figure 50: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 51: Colombia Analgesics Market Value & Volume, 2021-2026 ($)
Figure 52: Colombia GDP and Population, 2018-2019 ($)
Figure 53: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 54: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 55: Costa Rica Analgesics MarketCosta Rica 3D Printing  Market Value & Volume, 2021-2026 ($)
Figure 56: Costa Rica GDP and Population, 2018-2019 ($)
Figure 57: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 58: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 59: Europe Analgesics Market Value & Volume, 2021-2026 ($)
Figure 60: U.K Analgesics Market Value & Volume, 2021-2026 ($)
Figure 61: U.K GDP and Population, 2018-2019 ($)
Figure 62: U.K GDP – Composition of 2018, By Sector of Origin
Figure 63: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 64: Germany Analgesics Market Value & Volume, 2021-2026 ($)
Figure 65: Germany GDP and Population, 2018-2019 ($)
Figure 66: Germany GDP – Composition of 2018, By Sector of Origin
Figure 67: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 68: Italy Analgesics Market Value & Volume, 2021-2026 ($)
Figure 69: Italy GDP and Population, 2018-2019 ($)
Figure 70: Italy GDP – Composition of 2018, By Sector of Origin
Figure 71: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 72: France Analgesics Market Value & Volume, 2021-2026 ($)
Figure 73: France GDP and Population, 2018-2019 ($)
Figure 74: France GDP – Composition of 2018, By Sector of Origin
Figure 75: France Export and Import Value & Volume, 2018-2019 ($)
Figure 76: Netherlands Analgesics Market Value & Volume, 2021-2026 ($)
Figure 77: Netherlands GDP and Population, 2018-2019 ($)
Figure 78: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 79: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 80: Belgium Analgesics Market Value & Volume, 2021-2026 ($)
Figure 81: Belgium GDP and Population, 2018-2019 ($)
Figure 82: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 83: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 84: Spain Analgesics Market Value & Volume, 2021-2026 ($)
Figure 85: Spain GDP and Population, 2018-2019 ($)
Figure 86: Spain GDP – Composition of 2018, By Sector of Origin
Figure 87: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 88: Denmark Analgesics Market Value & Volume, 2021-2026 ($)
Figure 89: Denmark GDP and Population, 2018-2019 ($)
Figure 90: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 91: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 92: APAC Analgesics Market Value & Volume, 2021-2026 ($)
Figure 93: China Analgesics MarketValue & Volume, 2021-2026
Figure 94: China GDP and Population, 2018-2019 ($)
Figure 95: China GDP – Composition of 2018, By Sector of Origin
Figure 96: China Export and Import Value & Volume, 2018-2019 ($)Analgesics MarketChina Export and Import Value & Volume, 2018-2019 ($)
Figure 97: Australia Analgesics Market Value & Volume, 2021-2026 ($)
Figure 98: Australia GDP and Population, 2018-2019 ($)
Figure 99: Australia GDP – Composition of 2018, By Sector of Origin
Figure 100: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 101: South Korea Analgesics Market Value & Volume, 2021-2026 ($)
Figure 102: South Korea GDP and Population, 2018-2019 ($)
Figure 103: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 104: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 105: India Analgesics Market Value & Volume, 2021-2026 ($)
Figure 106: India GDP and Population, 2018-2019 ($)
Figure 107: India GDP – Composition of 2018, By Sector of Origin
Figure 108: India Export and Import Value & Volume, 2018-2019 ($)
Figure 109: Taiwan Analgesics MarketTaiwan 3D Printing  Market Value & Volume, 2021-2026 ($)
Figure 110: Taiwan GDP and Population, 2018-2019 ($)
Figure 111: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 112: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 113: Malaysia Analgesics MarketMalaysia 3D Printing  Market Value & Volume, 2021-2026 ($)
Figure 114: Malaysia GDP and Population, 2018-2019 ($)
Figure 115: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 116: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 117: Hong Kong Analgesics MarketHong Kong 3D Printing  Market Value & Volume, 2021-2026 ($)
Figure 118: Hong Kong GDP and Population, 2018-2019 ($)
Figure 119: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 120: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 121: Middle East & Africa Analgesics MarketMiddle East & Africa 3D Printing  Market Value & Volume, 2021-2026 ($)
Figure 122: Russia Analgesics MarketRussia 3D Printing  Market Value & Volume, 2021-2026 ($)
Figure 123: Russia GDP and Population, 2018-2019 ($)
Figure 124: Russia GDP – Composition of 2018, By Sector of Origin
Figure 125: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 126: Israel Analgesics Market Value & Volume, 2021-2026 ($)
Figure 127: Israel GDP and Population, 2018-2019 ($)
Figure 128: Israel GDP – Composition of 2018, By Sector of Origin
Figure 129: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 130:  Entropy Share, By Strategies, 2018-2019* (%)Analgesics Market
Figure 131:  Developments, 2018-2019*Analgesics Market
Figure 132: Company 1 Analgesics Market Net Revenue, By Years, 2018-2019* ($)
Figure 133: Company 1 Analgesics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 134: Company 1 Analgesics Market Net Sales Share, By Geography, 2018 (%)
Figure 135: Company 2 Analgesics Market Net Revenue, By Years, 2018-2019* ($)
Figure 136: Company 2 Analgesics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 137: Company 2 Analgesics Market Net Sales Share, By Geography, 2018 (%)
Figure 138: Company 3Analgesics Market Net Revenue, By Years, 2018-2019* ($)
Figure 139: Company 3Analgesics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 140: Company 3Analgesics Market Net Sales Share, By Geography, 2018 (%)
Figure 141: Company 4 Analgesics Market Net Revenue, By Years, 2018-2019* ($)
Figure 142: Company 4 Analgesics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 143: Company 4 Analgesics Market Net Sales Share, By Geography, 2018 (%)
Figure 144: Company 5 Analgesics Market Net Revenue, By Years, 2018-2019* ($)
Figure 145: Company 5 Analgesics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 146: Company 5 Analgesics Market Net Sales Share, By Geography, 2018 (%)
Figure 147: Company 6 Analgesics Market Net Revenue, By Years, 2018-2019* ($)
Figure 148: Company 6 Analgesics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 149: Company 6 Analgesics Market Net Sales Share, By Geography, 2018 (%)
Figure 150: Company 7 Analgesics Market  Net Revenue, By Years, 2018-2019* ($)
Figure 151: Company 7 Analgesics Market  Net Revenue Share, By Business segments, 2018 (%)
Figure 152: Company 7 Analgesics Market  Net Sales Share, By Geography, 2018 (%)
Figure 153: Company 8 Analgesics Market  Net Revenue, By Years, 2018-2019* ($)
Figure 154: Company 8 Analgesics Market  Net Revenue Share, By Business segments, 2018 (%)
Figure 155: Company 8 Analgesics Market  Net Sales Share, By Geography, 2018 (%)
Figure 156: Company 9 Analgesics Market  Net Revenue, By Years, 2018-2019* ($)
Figure 157: Company 9 Analgesics Market  Net Revenue Share, By Business segments, 2018 (%)
Figure 158: Company 9 Analgesics Market  Net Sales Share, By Geography, 2018 (%)
Figure 159: Company 10 Analgesics Market  Net Revenue, By Years, 2018-2019* ($)
Figure 160: Company 10 Analgesics Market  Net Revenue Share, By Business segments, 2018 (%)
Figure 161: Company 10 Analgesics Market  Net Sales Share, By Geography, 2018 (%)
Figure 162: Company 11 Analgesics Market  Net Revenue, By Years, 2018-2019* ($)
Figure 163: Company 11 Analgesics Market  Net Revenue Share, By Business segments, 2018 (%)
Figure 164: Company 11 Analgesics Market  Net Sales Share, By Geography, 2018 (%)
Figure 165: Company 12 Analgesics Market  Net Revenue, By Years, 2018-2019* ($)
Figure 166: Company 12 Analgesics Market  Net Revenue Share, By Business segments, 2018 (%)
Figure 167: Company 12 Analgesics Market  Net Sales Share, By Geography, 2018 (%)
Figure 168: Company 13Analgesics Market  Net Revenue, By Years, 2018-2019* ($)
Figure 169: Company 13Analgesics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 170: Company 13Analgesics Market  Net Sales Share, By Geography, 2018 (%)
Figure 171: Company 14 Analgesics Market  Net Revenue, By Years, 2018-2019* ($)
Figure 172: Company 14 Analgesics Market  Net Revenue Share, By Business segments, 2018 (%)
Figure 173: Company 14 Analgesics Market  Net Sales Share, By Geography, 2018 (%)
Figure 174: Company 15 Analgesics Market  Net Revenue, By Years, 2018-2019* ($)
Figure 175: Company 15 Analgesics Market  Net Revenue Share, By Business segments, 2018 (%)
Figure 176: Company 15 Analgesics Market  Net Sales Share, By Geography, 2018 (%)